UK markets closed

Pieris Pharmaceuticals, Inc. (PIRS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.09+0.13 (+1.45%)
At close: 04:00PM EDT
9.09 -0.00 (-0.02%)
After hours: 04:16PM EDT
Major holders
Insider roster

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases325,93213
Sales4,853,5527
Net shares purchased (sold)-4,527,62020
Total insider shares held92.01kN/A
% net shares purchased (sold)-98.00%N/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

KIRITSY CHRISTOPHER P
Director

Purchase at price 0.85 per share.Direct8,50025 May 202310,000

DEMUTH TIM
Officer

Purchase at price 1.71 per share.Direct10,26013 May 20226,000

OLWILL SHANE
Officer

Sale at price 5.00 - 5.15 per share.Direct196,38030 Aug 202138,400

OLWILL SHANE
Officer

Conversion of Exercise of derivative security at price 1.52 per share.Direct58,36830 Aug 202138,400

AQUILO CAPITAL MANAGEMENT, LLC
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.95 per share.Indirect5,605,00021 Jul 20201,900,000

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Sale at price 4.50 per share.Indirect224,97006 Sept 201950,000

KIRITSY CHRISTOPHER P
Director

Purchase at price 5.11 per share.Direct25,52514 Sept 20185,000

GERAGHTY JAMES A.
Director

Purchase at price 5.75 per share.Direct57,50015 May 201810,000

ORBIMED ADVISORS, L.L.C.
Shareholder

Sale at price 6.35 per share.Indirect6,350,00030 Apr 20181,000,000

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 8.98 per share.Indirect70,91513 Feb 20187,897

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 4.68 - 5.08 per share.Indirect37,67113 Feb 20187,897

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 7.35 per share.Indirect12,565,70703 Jan 20181,709,620

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 5.70 per share.Indirect841,52018 Dec 2017147,635

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 1.59 - 5.64 per share.Indirect308,05218 Dec 2017147,635

GERAGHTY JAMES A.
Director

Purchase at price 4.82 per share.Direct48,20017 Aug 201710,000

REINE ALLAN
Chief Financial Officer

Purchase at price 4.79 - 4.89 per share.Direct313,35017 Aug 201765,000

KIRITSY CHRISTOPHER P
Director

Conversion of Exercise of derivative security at price 1.59 per share.Direct7,95021 Apr 20175,000

MATIS LOUIS A. M.D.
Officer

Purchase at price 1.68 - 1.71 per share.Direct17,03714 Jun 201610,000

DEPTULA-HICKS DARLENE M
Chief Financial Officer

Purchase at price 1.66 per share.Direct8,30013 Jun 20165,000

YODER STEPHEN S
Chief Executive Officer

Purchase at price 1.68 per share.Direct10,08013 Jun 20166,000

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.75 per share.Indirect1,375,00006 Jul 2015500,000

KHUONG CHAU QUANG
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.75 per share.Indirect1,375,00006 Jul 2015500,000